Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/31/25
End: 12/31/27
Due: 12/31/28
Phase: N/A
Priority: Normal
Start: 08/21/24
End: 12/31/26
Due: 12/31/27
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Study to Assess the Efficacy of WSD0922-FU in Patients with C797S+ Advanced Non-small Cell Lung Cancer | NCT06868485 | Wayshine Biopharm, Inc. | user2@example.com | None | 2025-05-31 | 2027-12-31 | 2028-12-31 | - | - | 2025-07-14 |
| A Study to Assess the Efficacy and Safety of WSD0922-FU in Patients with EGFRm+ Advanced Non-small Cell Lung Cancer | NCT06631989 | Wayshine Biopharm, Inc. | user2@example.com | None | 2024-08-21 | 2026-12-31 | 2027-12-31 | - | - | 2025-07-14 |